文献速递系统性红斑狼疮

新ACC/AHA高血压定义对系统性红斑狼疮动脉粥样硬化血管事件的影响

Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus.
PubMed 文献 · Ann Rheum Dis · 2020-03-10

该研究基于多伦多狼疮队列1532例患者,按2年平均血压分为三组,随访10.8年发现124例动脉粥样硬化血管事件。平均血压130-139/80-89 mm Hg组事件发生率显著高于正常血压组,且该血压水平独立关联血管事件(HR 1.73)。作者建议将此血压水平作为降压治疗目标以减少心血管风险。

要点

  • 狼疮患者2年平均血压130-139/80-89 mm Hg者动脉粥样硬化血管事件发生率显著高于正常血压者。
  • 该血压水平独立关联动脉粥样硬化血管事件(HR 1.73,95%CI 1.13-2.65,p=0.011)。
  • 建议将血压控制在130-139/80-89 mm Hg以下作为狼疮患者降压治疗目标。

核心结论

  • 狼疮患者2年持续平均血压130-139/80-89 mm Hg者动脉粥样硬化血管事件发生率显著高于正常血压者,该血压水平应作为降压治疗目标。

研究设计与样本

  • 来自多伦多狼疮诊所的队列研究,纳入随访至少2年且无既往动脉粥样硬化血管事件的患者1532例。
  • 按2年平均血压分为≥140/90 mm Hg组、130-139/80-89 mm Hg组和<130/80 mm Hg组,随访至首次动脉粥样硬化血管事件或末次访视。
  • 采用多变量时间依赖分析调整其他危险因素。

主要发现

  • 155例(10.1%)平均血压≥140/90 mm Hg,316例(20.6%)130-139/80-89 mm Hg,1061例(69.3%)正常血压。
  • 平均随访10.8年,记录124例动脉粥样硬化血管事件。
  • 三组事件发生率分别为18.9、11.5和4.5/1000患者年(130-139/80-89 mm Hg组与正常血压组比较p=0.0007)。
  • 2年平均血压130-139/80-89 mm Hg独立关联动脉粥样硬化血管事件(HR 1.73,95%CI 1.13-2.65,p=0.011)。

关键数值与推荐

  • 2017年美国心脏病学会/美国心脏协会指南将高血压定义为≥130/80 mm Hg。
  • 研究分组血压阈值:≥140/90 mm Hg、130-139/80-89 mm Hg、<130/80 mm Hg。

临床怎么用

  • 对狼疮患者应关注2年平均血压水平,血压130-139/80-89 mm Hg者动脉粥样硬化血管事件风险已升高。
  • 降压治疗目标可考虑将血压控制在130-139/80-89 mm Hg以下以最小化心血管风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 2017 American College of Cardiology/American Heart Association guidelines defined hypertension at ≥130/80 mm Hg. Studies on patients with connective tissue diseases were not considered. Our aim was to assess the impact of this definition on atherosclerotic vascular events (AVEs) in systemic lupus erythematosus. PATIENTS METHODS: Individuals from the Toronto Lupus Clinic with at least 2 years of follow-up and no prior AVE were divided in three groups according to their mean blood pressure (BP) over that period (≥140/90 mm Hg, 130-139/80-89 mm Hg and <130/80 mm Hg). They were followed until the first occurrence of an AVE (fatal or non-fatal coronary artery disease, cerebrovascular event and peripheral vascular disease) or last visit. Groups were compared as per the baseline atherosclerotic risk factors. A multivariable time-dependent analysis was performed to adjust for the presence of other risk factors. RESULTS: Of 1532 patients satisfying the inclusion criteria, 155 (10.1%) had a BP ≥140/90 mm Hg, 316 (20.6%) 130-139/80-89 mm Hg and 1061 (69.3%) were normotensives. After a mean follow-up of 10.8 years, 124 AVEs were documented. The incidence rates were 18.9, 11.5 and 4.5 per 1000 patient-years for the three groups, respectively (p=0.0007 between the 130-139/80-89 mm Hg group and the normotensives). A mean BP of 130-139/80-89 mm Hg over the first 2 years was independently associated with the occurrence of AVEs (HR 1.73, 95% CI 1.13 to 2.65, p=0.011). CONCLUSION: Patients with lupus with a sustained mean BP of 130-139/80-89 mm Hg over 2 years had a significantly higher incidence of AVEs compared with normotensive individuals. This BP level should be the target for antihypertensive therapy to minimise their cardiovascular risk.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Tselios K, Gladman DD, Su J, et al. Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Ann Rheum Dis. 2020. PMID: 32156706. doi:10.1136/annrheumdis-2019-216764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。